Evidence map›Paper›PMID 40076902›Full record

ArticleInternational journal of molecular sciences2025

Revealing the Role of Beesioside O from

Shuyang Li, Juan Lu, Hongwei Xue, Yang Lou, Jia Liu, Yutian Wang, Haifeng Wu, Xi Chen

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuyang LiState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.ORCID 0009-0002-4425-9762
Juan LuState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.
Hongwei XueState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.ORCID 0009-0007-8409-1999
Yang LouState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.ORCID 0000-0001-9088-7984
Jia LiuDepartment of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.ORCID 0009-0005-4406-1598
Yutian WangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.
Haifeng WuState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.ORCID 0000-0002-1984-9114
Xi ChenState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.ORCID 0009-0000-7635-0451

Funding

CAMS Innovation Fund for Medical Science 2022-I2M-1-018
6 · The paper itself

Abstract

Breast cancer remains a leading cause of malignancy-related mortality among women, with rising global incidence. While surgical intervention is effective for early-stage breast cancer, drug therapy is indispensable, particularly for triple-negative breast cancer, where treatment options are still limited.

Indexed as

Antineoplastic Agents, PhytogenicBreast NeoplasmsSaponinsTriterpenesCell Line, TumorCell ProliferationFemaleHumansMolecular Docking SimulationMolecular Dynamics SimulationNetwork PharmacologySignal TransductionSTAT3 Transcription FactorAntineoplastic Agents, PhytogenicSaponinsSTAT3 protein, humanSTAT3 Transcription FactorTriterpenesanticancerBObreast cancermolecular dockingmolecular dynamics simulationnetwork pharmacology

Identifiers

PMID40076902
PMCPMC11899959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.